Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Clarity Pharmaceuticals Ltd. ( (AU:CU6) ) has issued an update.
Clarity Pharmaceuticals Ltd. has seen a change in the substantial holding of its shares by JPMorgan Chase & Co. and its affiliates, increasing their voting power from 6.32% to 7.33%. This shift indicates a growing interest and investment by JPMorgan in Clarity Pharmaceuticals, which could influence the company’s strategic decisions and market position. The change involves various transactions and securities lending agreements, reflecting active management of the investment by JPMorgan.
More about Clarity Pharmaceuticals Ltd.
YTD Price Performance: -47.24%
Average Trading Volume: 2,417,289
Technical Sentiment Signal: Buy
Current Market Cap: A$707M
For a thorough assessment of CU6 stock, go to TipRanks’ Stock Analysis page.